jeanny aragon-ching, md, summarize the ev103 study investigating enfortumab pembrolizumab
Published 4 years ago • 99 plays • Length 1:14
Download video MP4
Download video MP3
Similar videos
-
1:42
jeanny b. aragon-ching, md, facp, offers opinion on the role of chemotherapy in mcrpc
-
3:18
jeanny b. aragon-ching, md, facp, regarding the checkmate-9er trial presented at gu 2021
-
4:12
jeanny b. aragon-ching, md, facp, elaborates on the imvigor130 trial
-
1:09
david quinn, md summarizes the ev103 clinical study presented at asco gu 2020
-
0:31
jeanny b. aragon-ching, md, facp, shares how checkpoint inhibitors fit into rcc treatment algorithms
-
0:38
jeanny b. aragon-ching, md, facp, comments on 2nd line treatment options in rcc after i-o failure
-
1:13
jeanny aragon-ching, md, on next generation imaging and its impact on prostate cancer treatment
-
3:34
jeanny b. aragon-ching, md, facp, provides perspective on checkmate-274
-
0:48
jeanny b. aragon-ching, md, facp, on response rates for erdafitinib in metastatic bladder cancer
-
1:12
jeanny b. aragon-ching, md, facp, discusses new guidelines in treatment of metastatic bladder cancer
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
2:59
ambassador: adjuvant pembrolizumab in muscle-invasive urothelial carcinoma
-
2:22
adjuvant pembrolizumab and survival in renal-cell carcinoma | nejm
-
1:21
jeanny b. aragon-ching, md, facp, on molecular markers in high-risk muscle-invasive bladder cancer
-
1:08
novel approaches in treating merkel cell carcinoma
-
1:58
unmet needs in sr-agvhd and tr-agvhd
-
0:40
this is #classicalheme
-
2:00
future therapy options for muscle-invasive bladder cancer
-
1:16
germline testing in urothelial cancer
Clip.africa.com - Privacy-policy